{
  "id": "adv_mhgap#screening_cues_f596d1d7",
  "content": "the development process included: (i) identifying GDG membership.\npriority questions and outcomes; (ii) retrieval of the\nA chair and co-chair of the GDG were nominated by\nevidence; (iii) assessment and synthesis of the\nthe Steering Group and confirmed by the members\nevidence; (iv) formulation of the recommendations; and\nof the GDG before the start of the first meeting. The\n(v) planning for the dissemination, implementation,\nco-chair also had the role of guideline methodologist.\nimpact evaluation and updating of the guideline.\nThe chair and co-chair were selected based on their\nprevious experience chairing WHO GDGs and managing\n2.1 Contributors to the\ngroup processes, as well as their content expertise\nguideline\nand understanding of WHO guideline development\nprocesses. The role of the GDG was to support the\nThe different groups involved in the development of\ndefinition of the scope of the guideline and to examine\nthe guideline are described below. Further details are\nand interpret the evidence and formulate the final\nprovided in Annex 1.\nrecommendations during meetings, and to review the\ndraft guideline document.\n2.1.1 WHO Steering Group\nThe guideline development process was guided and 2.1.3 Topic Expert Groups\noverseen by the Steering Group, which comprised staff",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "screening_cues",
      "psychoeducation"
    ],
    "is_clinical": true,
    "is_advice": true
  },
  "index_text": "General — Screening Cues the development process included: (i) identifying GDG membership.\npriority questions and outcomes; (ii) retrieval of the\nA chair and co-chair of the GDG were nominated by\nevidence; (iii) assessment and synthesis of the\nthe Steering Group and confirmed by the members\nevidence; (iv) formulation of the recommendations; and\nof the GDG before the start of the first meeting. The\n(v) planning for the dissemination, implementation,\nco-chair also had the role of guideline methodologist.\nimpact evaluation and updating of the guideline.\nThe chair and co-chair were selected based on their\nprevious experience chairing WHO GDGs and managing\n2.1 Contributors to the\ngroup processes, as well as their content expertise\nguideline\nand understanding of WHO guideline development\nprocesses. The role of the GDG was to support the\nThe different groups involved in the development of\ndefinition of the scope of the guideline and to examine\nthe guideline are described below. Further details are\nand interpret the evidence and formulate the final\nprovided in Annex 1.\nrecommendations during meetings, and to review the\ndraft guideline document.\n2.1.1 WHO Steering Group\nThe guideline development process was guided and 2.1.3 Topic Expert Groups\noverseen by the Steering Group, which comprised staff The development process included: (i) identifying gdg membership. priority questions and outcomes; (ii) retrieval of the\na chair and co-chair of the gdg were nominated by\nevidence; (iii) đánh giá and synthesis of the\nthe..."
}